SG149817A1 - Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof - Google Patents
Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereofInfo
- Publication number
- SG149817A1 SG149817A1 SG200900078-7A SG2009000787A SG149817A1 SG 149817 A1 SG149817 A1 SG 149817A1 SG 2009000787 A SG2009000787 A SG 2009000787A SG 149817 A1 SG149817 A1 SG 149817A1
- Authority
- SG
- Singapore
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- receptor tyrosine
- synthesis
- intermediates
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title abstract 4
- 239000000543 intermediate Substances 0.000 title abstract 4
- 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- -1 4-substituted quinoline compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53732904P | 2004-01-16 | 2004-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG149817A1 true SG149817A1 (en) | 2009-02-27 |
Family
ID=34807094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200900078-7A SG149817A1 (en) | 2004-01-16 | 2005-01-14 | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
Country Status (20)
Country | Link |
---|---|
US (2) | US7432377B2 (es) |
EP (1) | EP1711467A2 (es) |
KR (1) | KR20060123545A (es) |
CN (1) | CN1930128A (es) |
AR (1) | AR047424A1 (es) |
AU (1) | AU2005206541A1 (es) |
BR (1) | BRPI0520812A2 (es) |
CA (1) | CA2553729A1 (es) |
CR (1) | CR8530A (es) |
EC (1) | ECSP066773A (es) |
GT (1) | GT200500008A (es) |
MY (1) | MY136959A (es) |
NO (1) | NO20063501L (es) |
PA (1) | PA8621501A1 (es) |
PE (1) | PE20050896A1 (es) |
RU (1) | RU2006127414A (es) |
SG (1) | SG149817A1 (es) |
TW (1) | TW200526219A (es) |
UA (1) | UA85698C2 (es) |
WO (1) | WO2005070890A2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7432377B2 (en) | 2004-01-16 | 2008-10-07 | Wyeth | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
EP1883621A2 (en) * | 2005-05-25 | 2008-02-06 | Wyeth | Methods of preparing 3-cyano-quinolines and intermediates made thereby |
JP2008542266A (ja) * | 2005-05-25 | 2008-11-27 | ワイス | 6−アルキルアミノキノリン誘導体の合成方法 |
CA2609186A1 (en) * | 2005-05-25 | 2006-11-30 | Wyeth | Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
TW200808728A (en) * | 2006-05-23 | 2008-02-16 | Wyeth Corp | Method of preparing 4-halogenated quinoline intermediates |
US8093246B2 (en) * | 2006-12-14 | 2012-01-10 | Lexicon Pharmaceuticals, Inc. | O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer |
PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
US8063220B2 (en) | 2007-06-22 | 2011-11-22 | Richter Gedeon Nyrt. | Sulfonyl-quinoline derivatives |
NO2300013T3 (es) | 2008-05-21 | 2018-02-03 | ||
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
MX360970B (es) | 2008-06-27 | 2018-11-23 | Avila Therapeutics Inc | Compuestos de heteroarilo y usos de los mismos. |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
JP5590040B2 (ja) | 2008-11-12 | 2014-09-17 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのピラジノピラジンおよび誘導体 |
CN103096716B (zh) | 2010-08-10 | 2016-03-02 | 西建阿维拉米斯研究公司 | Btk抑制剂的苯磺酸盐 |
NZ609957A (en) | 2010-11-01 | 2015-08-28 | Celgene Avilomics Res Inc | Heterocyclic compounds and uses thereof |
US9238629B2 (en) | 2010-11-01 | 2016-01-19 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
JP5957003B2 (ja) | 2010-11-10 | 2016-07-27 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | 変異体選択的egfr阻害剤およびその使用 |
EA201391626A1 (ru) | 2011-05-04 | 2014-03-31 | Ариад Фармасьютикалз, Инк. | Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака |
US9364476B2 (en) | 2011-10-28 | 2016-06-14 | Celgene Avilomics Research, Inc. | Methods of treating a Bruton's Tyrosine Kinase disease or disorder |
US9108927B2 (en) | 2012-03-15 | 2015-08-18 | Celgene Avilomics Research, Inc. | Salts of an epidermal growth factor receptor kinase inhibitor |
CN108658873B (zh) | 2012-03-15 | 2021-09-14 | 西建卡尔有限责任公司 | 表皮生长因子受体激酶抑制剂的固体形式 |
JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
US9126950B2 (en) | 2012-12-21 | 2015-09-08 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
MX2015009952A (es) | 2013-02-08 | 2015-10-05 | Celgene Avilomics Res Inc | Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos. |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
DK3179858T3 (da) | 2014-08-13 | 2019-07-22 | Celgene Car Llc | Forme og sammensætninger af en ERK-inhibitor |
AU2015308350B2 (en) | 2014-08-29 | 2020-03-05 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
EP3188642B1 (en) * | 2014-09-01 | 2018-05-30 | Electrolux Appliances Aktiebolag | Support assembly |
MX2018004109A (es) | 2015-10-05 | 2018-09-27 | Univ Columbia | Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías. |
CN105503720B (zh) * | 2015-12-31 | 2018-07-03 | 重庆威鹏药业有限公司 | 来那替尼中间体的制备方法 |
CN107417612A (zh) * | 2017-07-25 | 2017-12-01 | 广州大学 | 一种喹啉衍生物的合成方法 |
CN107501174A (zh) * | 2017-07-25 | 2017-12-22 | 广州大学 | 一种喹啉衍生物的合成方法 |
CN107501175A (zh) * | 2017-07-25 | 2017-12-22 | 广州大学 | 一种喹啉衍生物的合成方法 |
MA52288A (fr) | 2018-04-18 | 2021-04-07 | Constellation Pharmaceuticals Inc | Modulateurs d'enzymes de modification de méthyle, compositions et utilisations de ceux-ci |
CN112262143A (zh) | 2018-05-21 | 2021-01-22 | 星座制药公司 | 甲基修饰酶的调节剂、其组合物和用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
BR9809501A (pt) | 1997-05-28 | 2000-06-20 | Rhone Poulenc Rorer Pharma | Composto, composição farmacêutica, e, processos para inibir a atividade da tirosina quinase pdgf, para inibir a atividade da tirosina quinase lck, para inibir a proliferação celular, diferenciação ou liberação de mediador em um paciente, para tratar uma patologia ligada a um distúrbio hiperproliferativo, para tratar a restenose, e, para tratar inflamação em um paciente |
US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
AU6159499A (en) | 1998-09-29 | 2000-04-17 | Wyeth Holdings Corporation | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
US6297258B1 (en) * | 1998-09-29 | 2001-10-02 | American Cyanamid Company | Substituted 3-cyanoquinolines |
GB9910577D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
EP1294709A2 (en) | 2000-01-28 | 2003-03-26 | AstraZeneca AB | Quinoline derivatives and their use as aurora 2 kinase inhibitors |
US7253184B2 (en) | 2000-11-02 | 2007-08-07 | Astrazeneca Ab | 4-Substituted quinolines as antitumor agents |
UA77200C2 (en) * | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
EP1499593A4 (en) * | 2002-04-30 | 2006-02-01 | Yungjin Pharmacautical Co Ltd | CHINOLINE DERIVATIVES AS CASPASE-3 INHIBITOR, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
CL2004000016A1 (es) * | 2003-01-21 | 2005-04-15 | Wyeth Corp | Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina. |
US7365203B2 (en) * | 2003-09-15 | 2008-04-29 | Wyeth | Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
US7432377B2 (en) * | 2004-01-16 | 2008-10-07 | Wyeth | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
GB0509224D0 (en) | 2005-05-05 | 2005-06-15 | Chroma Therapeutics Ltd | Inhibitors of intracellular enzymatic activity |
-
2005
- 2005-01-14 US US11/036,408 patent/US7432377B2/en not_active Expired - Fee Related
- 2005-01-14 RU RU2006127414/04A patent/RU2006127414A/ru not_active Application Discontinuation
- 2005-01-14 CA CA002553729A patent/CA2553729A1/en not_active Abandoned
- 2005-01-14 GT GT200500008A patent/GT200500008A/es unknown
- 2005-01-14 KR KR1020067016319A patent/KR20060123545A/ko not_active Application Discontinuation
- 2005-01-14 UA UAA200609099A patent/UA85698C2/ru unknown
- 2005-01-14 TW TW094101148A patent/TW200526219A/zh unknown
- 2005-01-14 EP EP05711511A patent/EP1711467A2/en not_active Withdrawn
- 2005-01-14 SG SG200900078-7A patent/SG149817A1/en unknown
- 2005-01-14 PA PA20058621501A patent/PA8621501A1/es unknown
- 2005-01-14 WO PCT/US2005/001384 patent/WO2005070890A2/en active Application Filing
- 2005-01-14 CN CNA2005800077483A patent/CN1930128A/zh active Pending
- 2005-01-14 BR BRPI0520812-2A patent/BRPI0520812A2/pt not_active IP Right Cessation
- 2005-01-14 AU AU2005206541A patent/AU2005206541A1/en not_active Withdrawn
- 2005-01-15 MY MYPI20050166A patent/MY136959A/en unknown
- 2005-01-17 PE PE2005000069A patent/PE20050896A1/es not_active Application Discontinuation
- 2005-01-17 AR ARP050100169A patent/AR047424A1/es unknown
-
2006
- 2006-07-24 CR CR8530A patent/CR8530A/es not_active Application Discontinuation
- 2006-08-01 NO NO20063501A patent/NO20063501L/no not_active Application Discontinuation
- 2006-08-16 EC EC2006006773A patent/ECSP066773A/es unknown
-
2008
- 2008-08-28 US US12/200,120 patent/US20090030197A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20063501L (no) | 2006-09-28 |
ECSP066773A (es) | 2006-11-16 |
US20090030197A1 (en) | 2009-01-29 |
EP1711467A2 (en) | 2006-10-18 |
AR047424A1 (es) | 2006-01-18 |
MY136959A (en) | 2008-12-31 |
CA2553729A1 (en) | 2005-08-04 |
US7432377B2 (en) | 2008-10-07 |
UA85698C2 (ru) | 2009-02-25 |
GT200500008A (es) | 2005-08-16 |
CN1930128A (zh) | 2007-03-14 |
CR8530A (es) | 2008-09-23 |
WO2005070890A3 (en) | 2005-11-03 |
PE20050896A1 (es) | 2005-11-14 |
TW200526219A (en) | 2005-08-16 |
BRPI0520812A2 (pt) | 2009-10-06 |
WO2005070890A2 (en) | 2005-08-04 |
RU2006127414A (ru) | 2008-02-27 |
AU2005206541A1 (en) | 2005-08-04 |
US20050159446A1 (en) | 2005-07-21 |
KR20060123545A (ko) | 2006-12-01 |
PA8621501A1 (es) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG149817A1 (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
HU0400405D0 (en) | Novel compounds | |
HK1110588A1 (en) | Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
DK1713475T3 (da) | 1,3,5-trisubstituerede 4,5-dihydro-1H-pyrazol-derivater med CB1-antagonistisk aktivitet | |
SG153811A1 (en) | Quinazolinone derivatives useful as vanilloid antagonists | |
MY153719A (en) | Prokineticin 1 receptor antagonists | |
RS20090104A (en) | Pyrudo (2,3-d)pyrimidinone compounds and their use as p13 inhibitors | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
WO2007079163A3 (en) | Prokineticin 1 receptor antagonists | |
HK1080088A1 (zh) | 製備c-7取代的5-雄甾烯的方法 | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
WO2007047646A3 (en) | Substituted dihydro-isoindolones useful in treating kinase disorders | |
MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
WO2006047415A3 (en) | FACTOR Xa COMPOUNDS | |
GEP20084494B (en) | New heterocyclic carboxylic acid amide derivatives | |
ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
WO2006066044A3 (en) | Processes for producing 4-aminoquinazolines | |
WO2008147812A3 (en) | 4' substituted compounds having 5-ht6 receptor affinity | |
MX2009008324A (es) | Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6. | |
SI1893589T1 (sl) | Substituirani N-benzo(d)izoksazol-3-il-aminski derivati kot inhibitorji mGluR5, serotonin-(5-HT) in noradrenalinskih receptorjev in njihova uporaba za pripravo zdravil | |
TNSN07006A1 (en) | Novel heterocyclic compounds | |
EA200870045A1 (ru) | СУЛЬФОКСИМИННЫЕ ПРОИЗВОДНЫЕ КАК ИНГИБИТОРЫ p38 MAP КИНАЗЫ | |
TW200611900A (en) | Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof | |
WO2007034254A8 (en) | Amino-alkyl-amide derivatives as ccr3 receptor ligands | |
WO2008019279A3 (en) | Synthesis of piperazines, piperidines and related compounds |